UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.662-673

2011

Volltextzugriff (PDF)

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group

Clinical pharmacology and therapeutics, 2018-04, Vol.103 (4), p.599-618

2018

Volltextzugriff (PDF)

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

Rheumatology, 2008-03, Vol.47 (3), p.249-255

2008

Volltextzugriff (PDF)

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Clinical pharmacology and therapeutics, 2017-03, Vol.101 (3), p.341-358

2017

Volltextzugriff (PDF)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

BMC medicine, 2019-06, Vol.17 (1), p.110-14, Article 110

2019

Volltextzugriff (PDF)

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials

Investigational new drugs, 2013-08, Vol.31 (4), p.1087-1094

2013

Volltextzugriff (PDF)

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.953-963

2017

Volltextzugriff (PDF)

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

Journal of antimicrobial chemotherapy, 2000-08, Vol.46 (2), p.171-179

2000

Volltextzugriff (PDF)

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

Breast cancer research and treatment, 2015-10, Vol.153 (3), p.583-590

2015

Volltextzugriff (PDF)

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL)

Pharmazie, 2023-08, Vol.78 (8), p.107-112

2023

Volltextzugriff (PDF)

Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review

Cancer treatment reviews, 2012-08, Vol.38 (5), p.505-514

2012

Volltextzugriff (PDF)

Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer

Breast cancer research and treatment, 2023-06, Vol.199 (3), p.471-478

2023

Volltextzugriff (PDF)

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial

Neurology, 2010-04, Vol.74 (15), p.1203-1207

2010

Volltextzugriff (PDF)

The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs

Clinical pharmacokinetics, 2013-10, Vol.52 (10), p.833-854

2013

Volltextzugriff (PDF)

Pharmacogenetics: From Bench to Byte

Clinical pharmacology and therapeutics, 2008-05, Vol.83 (5), p.781-787

2008

Volltextzugriff (PDF)

Effect of CYP3A422, CYP3A53, and CYP3A combined genotypes on tamoxifen metabolism

European journal of clinical pharmacology, 2017-12, Vol.73 (12), p.1589-1598

2017

Volltextzugriff (PDF)

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse

Scientific reports, 2021-01, Vol.11 (1), p.415-12, Article 415

2021

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients

European journal of clinical pharmacology, 2016-02, Vol.72 (2), p.163-174

2016

Volltextzugriff (PDF)

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy

Cancer treatment reviews, 2005-04, Vol.31 (2), p.90-105

2005

Volltextzugriff (PDF)

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer

Annals of oncology, 2011-05, Vol.22 (5), p.1147-1153

2011

Volltextzugriff (PDF)

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.363-373

2013

Volltextzugriff (PDF)

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

Clinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.503-510

2012

Volltextzugriff (PDF)

The Exon-3 Deleted Growth Hormone Receptor Polymorphism Predisposes to Long-Term Complications of Acromegaly

The journal of clinical endocrinology and metabolism, 2009-12, Vol.94 (12), p.4671-4678

2009

Volltextzugriff (PDF)

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

European journal of cancer (1990), 2014-01, Vol.50 (2), p.388-396

2014

Volltextzugriff (PDF)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

European journal of clinical pharmacology, 2012-04, Vol.68 (4), p.363-370

2012

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(260)

Publikationsform

Artikel
(299)
Tagungsberichte
(1)

Sprache

Englisch
(300)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL)

Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review

Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial

The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs

Pharmacogenetics: From Bench to Byte

Effect of CYP3A422, CYP3A53, and CYP3A combined genotypes on tamoxifen metabolism

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

The Exon-3 Deleted Growth Hormone Receptor Polymorphism Predisposes to Long-Term Complications of Acromegaly

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

Suchergebnisse filtern